SCD and Familial prostate cancer: Furthermore, SCD1 silencing reduces the survival of prostate cancer cell lines [65] and cell proliferation and tumor in lung cancer and animal models [48,66] reinforcing the idea that SCD can be a novel therapeutic target against some tumors.